Ben A Derm Shp 2.5% 2.5 % Shampoo is a Health Canada–registered veterinary drug (DIN 00583324) held by Rogar/Stb Inc., containing Benzoyl Peroxide. Health Canada lists its status as Cancelled Post Market (status date 10 Sep 1996). Nexara Health has matched 358 registrations of Benzoyl Peroxide across 17 other regulated markets.
Health Canada registration
| DIN | 00583324 |
|---|---|
| Brand name | Ben A Derm Shp 2.5% |
| Active ingredient | Benzoyl Peroxide |
| Strength | 2.5 % |
| Dosage form | Shampoo |
| Route | Topical |
| Company | Rogar/Stb Inc. |
| Status | Cancelled Post Market — 10 Sep 1996 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Benzoyl Peroxide registered in other markets
358 registrations of the same molecule in 17 national registries outside Canada (first 64 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Benzaknen 10 % Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Benzaknen 5 % Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Benzaknen 5 % Susp. zum Auftragen | — | 50ml | green box | eEKO (Erstattungskodex) | |
| Bahrain | Benzac Ac | Galderma International, France. | 5 % | Gel | POM | NHRA |
| Bahrain | Benzac Ac | Galderma International, France. | 2.5 % | Gel | POM | NHRA |
| Bulgaria | Acne Out BP | Биотрейд България ООД | 5% gel | гел | Без лекарско предписание | BDA |
| Czech Republic | Akneroxid | — | 50MG/G | Gel | R | SUKL DLP |
| Czech Republic | Akneroxid | — | 100MG/G | Gel | R | SUKL DLP |
| Hong Kong | Benzac Ac 10 Gel 10% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac 2 1/2 Gel 2.5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac 5 Gel 5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac Wash 5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Bluecross Benzoyl Peroxide Acne Gel 5% W/W | Noble Health Co., Ltd | Registered | DH Drug Office | ||
| Hong Kong | Oxy Cover Cream 10% Maximum Strength | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Hong Kong | Oxy-10 Lotion 10% | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Hong Kong | Oxy-5 Lotion 5% | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Iceland | Basiron AC | Parlogis - óskráð lyf | 5 % | hlaup | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Acnecide 5% w/w Gel | Galderma International | Gel | Marketed | HPRA | |
| Ireland | Acnecide Wash 5 % w/w Gel | Galderma International | Gel | Marketed | HPRA | |
| Ireland | Brevoxyl 40 mg/g cream | Avianta Pharma EU Limited | Cream | Not marketed | HPRA | |
| Luxembourg | AKNEROXID GEL 100 mg / 1 g 1*1 GEL 50 G | — | P | CNS liste positive | ||
| Luxembourg | AKNEROXID GEL 50 mg / 1 g 1*1 GEL 50 G | — | P | CNS liste positive | ||
| Luxembourg | BENZAC-10 GEL 100 mg / 1 mL 1*1 GEL 40 G | — | P | CNS liste positive | ||
| Luxembourg | BENZAC-5 GEL 50 mg / 1 mL 1*1 tube 40 g | — | P | CNS liste positive | ||
| Malaysia | Benzac Ac 5% Gel | Galderma Malaysia Sdn Bhd | Non Prescription | PRODUCT APPROVED | NPRA | |
| Netherlands | Benzac 100 mg/ml, gel | Galderma Benelux B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzac 50 mg/ml, gel | Galderma Benelux B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzoylperoxide Teva 100 mg/g, hydrogel | Teva Nederland B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzoylperoxide Teva 50 mg/g, hydrogel | Teva Nederland B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Poland | Akneroxid 10 | Almirall Hermal GmbH | 100 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Akneroxid 5 | Almirall Hermal GmbH | 50 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Benzacne | Orifarm Healthcare A/S | 50 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Benzacne | Orifarm Healthcare A/S | 100 mg/g | Żel | Bezterminowe | URPL RPL |
| Saudi Arabia | Acnezoyl 2.5 % Gel | — | 2.5 | Inactive | SFDA | |
| Saudi Arabia | Acnezoyl 5% Gel | — | 5 | Inactive | SFDA | |
| Saudi Arabia | Panoxyl 10 Acne Gel | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Panoxyl 5 Lotion | — | 5 | Inactive | SFDA | |
| Taiwan | 080 Middle Antiacne Cream | 澳斯麗國際股份有限公司淡水廠 | 乳膏劑 | Registered | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | A.d.f. Cream 5% "D.s" (Benzoyl Peroxide) | 臺灣派頓化學製藥股份有限公司岡山廠 | 軟膏劑 | Registered | TFDA | |
| Turkey | Triakne %5 Emulsiyojel 50 g | Orva İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| United Arab Emirates | Benzac AC ® 2.5% | LABORATOIRES GALDERMA, France, Alby Sur Cheran | 2½% | Gel | Active | EDE |
| United Arab Emirates | Benzac AC ® 5% | LABORATOIRES GALDERMA, France, Alby Sur Cheran | 5% | Gel | Active | EDE |
| United Kingdom | Benzoyl peroxide 10% / Potassium hydroxyquinoline sulfate 0.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% lotion | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% wash | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 2.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 2.5% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 3% / Clindamycin 1% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 4% cream | — | 0001 | NHS dm+d VMP | ||
| United States | 10 Acne Med | Face Reality, Inc. | Gel | listed | FDA NDC | |
| United States | 111 Medco Benzoyl Peroxide | 111 Medco | Soap | listed | FDA NDC | |
| United States | 2.5 Acne Med | Face Reality, Inc. | Gel | listed | FDA NDC | |
| United States | 24 Hour Acne Serum | Drmtlgy, LLC | Gel | listed | FDA NDC | |
| United States | 5 Acne Med | Face Reality, Inc. | Gel | FDA NDC | ||
| United States | 5 Percent Benzoyl Peroxide Cleanser | Brand Evangelists for Beauty Limited | Gel | listed | FDA NDC | |
| United States | Acne Cleanser | Walmart, Inc. | Cream | listed | FDA NDC | |
| United States | Acne Cleanser | Meijer, Inc. | Cream | listed | FDA NDC |
See every manufacturer of Benzoyl Peroxide worldwide →
Regulator price references for Benzoyl Peroxide
Published list or reimbursement prices for Benzoyl Peroxide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Benzaknen 5 % Gel | 30000mg | 30g | 3.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Benzaknen 10 % Gel | 30000mg | 30g | 4.30 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Benzaknen 5 % Susp. zum Auftragen | 50ml | 50ml | 5.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Benzac Ac | 2.5pct | 60G | 1.23 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Benzac Ac | 5pct | 60G | 1.72 BHD | retail (max) | NHRA | 2026-09-01 |
| Iceland | Basiron AC | 5pct | túpa | 1,513.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Luxembourg | AKNEROXID GEL 50 mg / 1 g 1*1 GEL 50 G | 50mg/1000mg | 6.75 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | AKNEROXID GEL 100 mg / 1 g 1*1 GEL 50 G | 100mg/1000mg | 7.57 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BENZAC-5 GEL 50 mg / 1 mL 1*1 tube 40 g | 50mg/1ml | 8.68 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BENZAC-10 GEL 100 mg / 1 mL 1*1 GEL 40 G | 100mg/1ml | 9.24 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Saudi Arabia | Acnezoyl 2.5 % Gel | 2.5pct | 4.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Acnezoyl 5% Gel | 5pct | 8.30 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Panoxyl 5 Lotion | 10.40 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Panoxyl 10 Acne Gel | 14.70 SAR | public | SFDA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ben A Derm Shp 2.5% (DIN 00583324) marketed in Canada?
No. Health Canada lists DIN 00583324 as Cancelled Post Market as of 10 Sep 1996.
Who holds the Canadian licence for this product?
Rogar/Stb Inc. is the company of record in the Health Canada Drug Product Database.
Is Benzoyl Peroxide registered outside Canada?
Yes — Nexara Health has matched 358 registrations in 17 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00583324, status date 1996-09-10; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00583324, status date 1996-09-10; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 00583324, status date 1996-09-10; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.